Newsfeeds - Spark Newswire

1 minute read

Earnings

Brainstorm Cell Earnings Preview

Today, 7:57 PM

Brainstorm Cell (NASDAQ:BCLI) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Brainstorm Cell will report an earnings per share (EPS) of $-0.13.

BCLI

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 7:57 PM

On Wednesday, 807 companies reached new 52-week lows.

AADI

3 minute read

Earnings Scheduled For March 28, 2022

By Benzinga Insights

Today, 7:57 PM

Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.

ABOS

4 minute read

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

By Shanthi Rexaline

Today, 7:57 PM

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

ADMP

1 minute read

Earnings

Preview: Brainstorm Cell’s Earnings

By Benzinga Insights

Today, 7:57 PM

Brainstorm Cell (NASDAQ:BCLI) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Brainstorm Cell will report an earnings per share (EPS) of $-0.20.

BCLI

3 minute read

The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study

By Shanthi Rexaline

Today, 7:57 PM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ADAG

4 minute read

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

By Shanthi Rexaline

Today, 7:57 PM

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.

ACIU

2 minute read

FDA
News

BrainStorm Cell Therapeutics Announces FDA Authorizes Further NurOwn Dosing Under Expanded Access Program

By Benzinga Newsdesk

Today, 7:57 PM

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced plans for a dosing extension of NurOwn® for participants who completed the

BCLI

3 minute read

34 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 7:57 PM

Gainers Exicure, Inc. (NASDAQ: XCUR) rose 41.8% to $0.3830. Exicure’s Audit Committee recently concluded that Grant Corbett misreported raw data from certain R&D experiments related to XCUR-FXN preclinical program.

ADGI

3 minute read

20 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 7:57 PM

Gainers MIND Technology, Inc. (NASDAQ: MIND) rose 37.2% to $1.88 in pre-market trading after the company reported it entered into a Cooperative Research and Development Agreement with the United States Navy's Naval Surface Warfare Center, Panama City Division.

ALZN